Compare BioSyntech Canada vs Walnut Technologies
Customers evaluate the quality of BioSyntech Canada's products using the following success metrics.
Overview
BioSyntech Canada is 30 yrs old and is based in Canada.
BioSyntech specializes in the discovery, development and manufacturing of biotherapeutic thermogels for regenerative medicine and therapeutic delivery. Its platform technology is a family of hydrogels that can be injected or applied to specific sites and which offer beneficial properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds.
Walnut Technologies is 25 yrs old and is based in United States.
Non-invasive therapeutic ultrasound devices used to accelerate drug delivery and deliver perfusion therapy for stroke and peripheral thrombosis. Acquired privately in 2003.
Demo Video
Leadership
Jeanne Bertonis (President)
Albert Kyle (Chief Executive Officer, President)
Investors
Pappas Ventures, ProQuest Investments
One Equity Partners, Radius Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because BioSyntech Canada has not claimed their profile.
Work for BioSyntech Canada? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for BioSyntech Canada?
Claim your profile now.
Information not available because Walnut Technologies has not claimed their profile.
Work for Walnut Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Walnut Technologies?
Claim your profile now.